Rob Reynish asks readers to look behind the political labels to what science can do to keep our food industries from falling ...

CollPlant Biotechnologies ranks at the bottom among peers for Revenue Growth, with a negative growth rate of -28.11%. It also ...

The rhabdomyosarcoma market is expanding as unmet needs in pediatric and young-adult populations drive increased R&D and clinical activity. Additionally, the launch of emerging therapies such ...

Gene-edited crops are no safer than GMOs, and fast-tracking regulatory approval could trigger a costly backlash.

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication ...

The genetic code is the recipe for life, and provides the instructions for how to make proteins, generally using just 20 ...

No doubt the New Zealand Gene Technology Bill, currently awaiting its Second Reading, which will liberalise decisions about gene technology experiments and place them in the hands of a single ...

EVE is a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale.

Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in ...

Researchers around the world are studying how the human brain achieves its extraordinary complexity. A team at the Central ...

The recent grants, totaling $572,600, will fund research projects in fields ranging from biology to artificial intelligence.

DelveInsight's Rhabdomyosarcoma Market Insights report includes a comprehensive understanding of current treatment practices, ...